UTI Healthcare Fund Direct-Growth
NAV
₹303.2661
as on 03 Apr 2025, 11:11 PM
₹4.5911(1.54%)
Last Change
Scheme Information
UTI Healthcare Fund Direct-Growth
as of 28 Feb 2025, 05:30 AM
₹1,057.17 Cr
1.22%
0.44%
Open-End
Growth
Exit load of 1% if redeemed within 30 days.
BSE Healthcare Total Return Index
View
Sectors Holding in this Mutual Fund
Healthcare
99.55%
₹1,052.42 Cr
Others
0.45%
₹4.76 Cr
Healthcare
99.55%
₹1,052.42 Cr
Others
0.45%
₹4.76 Cr
Sun Pharmaceutical Industries Ltd.
11.34%
₹119.88 Cr
Cipla Ltd.
6.61%
₹69.88 Cr
Dr. Reddy's Laboratories Ltd.
5.66%
₹59.84 Cr
Ajanta Pharma Ltd.
5.29%
₹55.92 Cr
Apollo Hospitals Enterprise Ltd.
4.07%
₹43.03 Cr
Others
67.03%
₹708.62 Cr
Sun Pharmaceutical Industries Ltd.
11.34%
₹119.88 Cr
Cipla Ltd.
6.61%
₹69.88 Cr
Dr. Reddy's Laboratories Ltd.
5.66%
₹59.84 Cr
Ajanta Pharma Ltd.
5.29%
₹55.92 Cr
Apollo Hospitals Enterprise Ltd.
4.07%
₹43.03 Cr
Others
67.03%
₹708.62 Cr
Funds in this Category
This fund's returns: 20.87%
SBI Healthcare Opportunities Fund Direct Plan-Growth
Min. Investment
₹500
24.33
Category Returns
15.79%
24.33%
3Y Returns
24.33 %
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
Min. Investment
₹100
24.00
Category Returns
15.79%
24.33%
3Y Returns
24.00 %
DSP Healthcare Fund Direct - Growth
Min. Investment
₹100
21.19
Category Returns
15.79%
24.33%
3Y Returns
21.19 %
About UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is 21.06%, in last 3 years is 76.86% and 535.51% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
| AUM: | ₹1,057.17 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
UTI Mutual Fund
Address
Investment Performance
₹ 1,00,000
would have given a return of
₹1,10,871
₹1,21,647
₹1,71,530
₹1,76,857
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
Profit (absolute return)
₹76,857
76.86%
Investment Returns
Scheme Riskometer
Investors understand that their principal will be at very high risk
